000			03636pam a2200409 a 4500
001			3527288
003			OSt
005			20230925054503.0
008			961120s1997 nyua b 001 0 eng c
010			_a 96049906
020			_a0824798090 (hardcover : alk. paper)
040			_aBUL _cBUL _dBUL _beng _erda
082			_aQS 532.5 E7 ES6 1997 _bE7 ES6 1997
245	0	4	_aThe endothelium in clinical practice : _bsource and target of novel therapies / _cedited by Gabor M. Rubanyi, Victor J. Dzau.
260			_aNew York : _bM. Dekker, _cc1997.
300			_axvi, 551 p. : _bill. ; _c24 cm.
490	1		_aFundamental and clinical cardiology ; _v29
504			_aIncludes bibliographical references and index.
505			_aContent I. The Endothelium as the Source of Novel Therapies 1. Prostacyclin (Prostaglandin I2) and Atherosclerosis, Karsten Schroer 2. Prostacyclin and Thromboxane: Role in Ischemic Heart Disease, Jawahar L. Mehta and Baichun C. Yang 3. Clinical Use of Prostacyclins, John A. Dormandy and Glyn Belcher 4. Nitric Oxide Synthases: Enzymology and Mechanism-Based Inhibitors, John F. Parkinson and Gary Phillips 5. Endothelin: From Basic to Pathophysiological Research, Katsutoshi Goto 6. Transmigration of Leukocytes, B. Stein, Y. Khew-Goodall, J. Gamble, and M. A. Vadas 7. Transforming Growth Factor-b and Cardiovascular Protection, David J. Grainger and James C. Metcalfe 8. Coagulation Factors, Michael Kalafatis, Jack O. Egan, and Kenneth G. Mann II. The Endothelium as a Target for Novel Therapies 9. Endothelial Dysfunction and Vascular Disease, Paul M. Vanhoutte, Louis Perrault, and Jean Paul Vilaine 10. Complement and Endothelium: Novel Complement-Inhibitory Therapeutics, Una S. Ryan 11. The Receptor for Advanced Gycation Endproducts: Implications for the, Development of Diabetic Vascular Disease, Osamu Hori, Shi Du Yan, and Ann Marie Schmidt 12. Hypertension, Pierre Moreau and Thomas F. Luscher 13. Arterial Restenosis, Michael A. Reidy and Stephen M. Schwartz 14. Pathobiology and Clinical Consequences of Plaque Rupture, Richard Gallo, Juan J. Badimon, James H. Chesebro, Valentin Fuster, and Lina Badimon 15. Isoprostanes and Antioxidant Therapy in Human Diseases, Emma A. Meagher and Garrett A. FitzGerald 16. Vasculoprotection by Estrogen Contributes to Gender Difference in Cardiovascular Diseases: Potential Mechanism and Role of Endothelium, Katalin Kauser and Gabor M. Rubanyi 17. Lipoprotein(a): Insights from Transgenic Mice, Steven D. Hughes and Edward M. Rubin 18. Gene TherapyGene Therapy with Vascular Endothelial Growth Factor, Jeffrey M. Isner 19. Vascular Disease and the Prospect of Gene Therapy, Heiko E. von der Leyen and Victor J. Dzau
650		0	_aVascular endothelium _xPathophysiology.
650		0	_aVascular endothelium _xPhysiology.
650		0	_aEndothelium.
650		0	_aEndothelins.
650		0	_aThromboxanes.
650		0	_aProstacyclin.
650	1	2	_aHeart Diseases _xtherapy.
650	2	2	_aHeart Diseases _xphysiopathology.
650	2	2	_aEndothelium _xphysiology.
700	1		_aRubanyi, Gabor M., _d1947-
700	1		_aDzau, Victor J.
830		0	_aFundamental and clinical cardiology ; _vv. 29.
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0647/96049906-d.html
906			_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg
942			_2ddc _cBO _hQS 532.5 E7 ES6 1997 _i1 _kQS 532.5 _mE7 ES6 1997
999			_c9384 _d9384